Dr. Sarah Jennifer Frattali, MD

Dr. Frattali practices at Carroll Medical Group in Hampstead, Maryland.

Dr. Frattali's NPI, 1649344409, was assigned on November 20, 2006. Dr. Frattali graduated from University of Maryland School of Medicine - Baltimore in 2001. Dr. Frattali holds Maryland license D0062400.

Dr. Frattali's primary practice is Carroll Medical Group, at 4231 N Woods Trl Carroll Medical Group, Hampstead, MD 21074-3128. The practice phone is (410) 374-9391.

Dr. Frattali's primary practice is Carroll Medical Group in Hampstead, Maryland. Dr. Frattali is also affiliated with WellSpan Gettysburg Hospital. The medical group on file is Carroll Medical Group. Dmand AI also links Dr. Frattali to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frattali practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Frattali's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Frattali is board certified in internal medicine by the American Board of Internal Medicine. Dr. Frattali is licensed in Maryland.

Dmand AI lists acute gastroduodenitis, acute sinusitis, acute skin infection, adjustment disease, arthritis, carpal tunnel syndrome, cerebrovascular disease and chronic anemia among the conditions Dr. Frattali treats.

CMS data shows 420 Medicare services from Dr. Frattali across 9 procedure codes in 2024, for 158 Medicare patients. Medicare paid $27,243 for them. Every service was in an office.

CMS counts 158 Medicare patients who saw Dr. Frattali in 2024. The largest group is 65 to 74, with 77 patients. 68% of them have high cholesterol, and 61% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Frattali's median patient age at 56, with 62% women.

In 2024, Dr. Frattali wrote 3,435 Medicare Part D claims for 241 patients. 89% of them were for generic drugs. CMS names the drug for 2,902 of them, across 97 drugs with 11 or more claims each, at $306,135 in total drug cost. In 2023, CMS named 2,541 claims across 84 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Frattali for performance year 2024, reported as part of a group. Dr. Frattali accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Frattali as offering telehealth.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 223 general payments to Dr. Frattali from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $805.

Dmand AI lists 1 award for Dr. Frattali.

Dr. Frattali graduated from University of Maryland School of Medicine - Baltimore in 2001. Dr. Frattali is a member of AAP and ACP.

Dr. Frattali is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, CareFirst BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.